BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 637996)

  • 1. Plasma concentrations of pancuronium during predetermined intensities of neuromuscular blockade.
    Shanks CA; Somogyi AA; Triggs EJ
    Br J Anaesth; 1978 Mar; 50(3):235-9. PubMed ID: 637996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma concentrations of pancuronium and neuromuscular blockade after injection into the isolated arm, bolus injection, and continuous infusion.
    Agoston S; Feldman SA; Miller RD
    Anesthesiology; 1979 Aug; 51(2):119-22. PubMed ID: 453611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response and plasma concentration-response relationships of pancuronium in man.
    Shanks CA; Somogyi AA; Triggs EJ
    Anesthesiology; 1979 Aug; 51(2):111-8. PubMed ID: 453610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1985 Nov; 57(11):1052-9. PubMed ID: 2864943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged paralysis after long-term, high-dose infusion of pancuronium in anaesthetized cats.
    Henning RH; Houwertjes MC; Scaf AH; den Hertog A; Agoston S
    Br J Anaesth; 1993 Sep; 71(3):393-7. PubMed ID: 8398522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variations in pancuronium requirement, plasma concentration, and urinary excretion induced by cardiopulmonary bypass with hypothermia.
    d'Hollander AA; Duvaldestin P; Henzel D; Nevelsteen M; Bomblet JP
    Anesthesiology; 1983 Jun; 58(6):505-9. PubMed ID: 6859580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolongation of pancuronium-induced neuromuscular blockade by intravenous infusion of nitroglycerin.
    Glisson SN; El-Etr AA; Lim R
    Anesthesiology; 1979 Jul; 51(1):47-9. PubMed ID: 110176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diuretic-induced hypokalaemia, pancuronium neuromuscular blockade and its antagonism by neostigmine.
    Miller RD; Roderick LL
    Br J Anaesth; 1978 Jun; 50(6):541-4. PubMed ID: 666926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle blood flow and rate of recovery from pancuronium neuromuscular blockade in dogs.
    Heneghan CP; Findley IL; Gillbe CE; Feldman SA
    Br J Anaesth; 1978 Nov; 50(11):1105-8. PubMed ID: 718779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paralysis in the critically ill: intermittent bolus pancuronium compared with continuous infusion.
    de Lemos JM; Carr RR; Shalansky KF; Bevan DR; Ronco JJ
    Crit Care Med; 1999 Dec; 27(12):2648-55. PubMed ID: 10628604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does intravenous infusion of nitroglycerin potentiate pancuronium- and vecuronium-induced neuromuscular blockade?
    Schwarz S; Agoston S; Houwertjes MC
    Anesth Analg; 1986 Feb; 65(2):156-60. PubMed ID: 2867718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Edrophonium antagonizes combined lidocaine-pancuronium and verapamil-pancuronium neuromuscular blockade in cats.
    Carpenter RL; Mulroy MF
    Anesthesiology; 1986 Nov; 65(5):506-10. PubMed ID: 3777479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between the continuous infusion of vecuronium and the intermittent administration of pancuronium and vecuronium.
    Noeldge G; Hinsken H; Buzello W
    Br J Anaesth; 1984 May; 56(5):473-7. PubMed ID: 6144316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of verapamil on indirect muscle twitch responses.
    Kraynack BJ; Lawson NW; Gintautas J; Tjay HT
    Anesth Analg; 1983 Sep; 62(9):827-30. PubMed ID: 6603798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of neuromuscular function in the perfused rat diaphragm after succinylcholine and pancuronium blockade.
    Bartkowski RR
    Anesthesiology; 1983 May; 58(5):409-13. PubMed ID: 6837993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of pancuronium bromide.
    Somogyi AA; Shanks CA; Triggs EJ
    Eur J Clin Pharmacol; 1976 Sep; 10(5):367-72. PubMed ID: 789085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic modelling with pancuronium.
    Evans MA; Shanks CA; Brown KF; Triggs EJ
    Eur J Clin Pharmacol; 1984; 26(2):243-50. PubMed ID: 6723764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of neuromuscular blockade and reversibility of AH 8165 and pancuronium bromide in man.
    Camu F; Sanders M; D'Hollander A
    Acta Anaesthesiol Belg; 1976; 27 suppl():80-5. PubMed ID: 13601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyridostigmine as an antagonist of d-tubocurarine-induced and pancuronium-induced neuromuscular blockade.
    Ravin MB
    Anesth Analg; 1975; 54(3):317-21. PubMed ID: 1169015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.